Breathing exercises with or without the Aerobika device for bronchiectasis
Compares breathing exercises alone against exercises plus Aerobika in adults with bronchiectasis.
Key facts
- Who runs it
- Chungbuk National University Hospital
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Comparing Active Cycle of Breathing Techniques (ACBT) and Aerobika in Treating Bronchiectasis in Korea
- Status
- Not yet recruiting
- People taking part
- 100 people, planned
- Started
- 1 Jul 2025
- Expected to end
- 1 Jul 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Active Cycle of Breathing Technique (ACBT) and Oscillatory Positive Expiratory Pressure (OPEP) group
- Active Cycle of Breathing Technique (ACBT) group
- Record updated
- 25 June 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with bronchiectasis (widened, damaged airways in the lungs) who have frequent flare-ups. It compares a breathing technique alone with the same technique plus the Aerobika device.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Bronchiectasis in one or more lobes of the lung, seen on a chest CT scan. People must have had 3 or more flare-ups within 1 year.
- Earlier treatment
- People who have used an OPEP device before cannot join.
Main reasons for not taking part
- Bronchiectasis caused by cystic fibrosis, or by interstitial lung disease (lung scarring)
- Pregnancy
- Unable to cope with harder breathing work, or unstable blood pressure and circulation
- Coughing up blood now or in the past
- Collapsed lung (pneumothorax) that has not been treated
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- 18 years of age or older
- Patients diagnosed with bronchiectasis involving one or more lobes on chest computed tomography (CT)
- Patients experiencing frequent exacerbations (3 or more exacerbations) within 1 year
- Patients able and willing to use the Aerobika device (OPEP)
Who cannot take part
- Traction bronchiectasis due to interstitial lung disease (ILD)
- Patients with a history of OPEP device use
- Patients with a past or current history of hemoptysis (pulmonary bleeding) and untreated pneumothorax
- Diagnosis of bronchiectasis due to cystic fibrosis
- Pregnant patients
- Patients who cannot tolerate increased breathing work
- Hemodynamic instability (e.g., unstable blood pressure)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Title:
Read full original descriptionShow less
Comparison of Effectiveness Between Active Cycle of Breathing Techniques (ACBT) and Oscillating Positive Expiratory Pressure (OPEP, Aerobika) Device Assisted Treatment in Patients With Bronchiectasis in Korea: A Randomized Controlled Trial
Purpose:
This study aims to evaluate the effectiveness of Active Cycle of Breathing Techniques (ACBT) alone versus ACBT combined with an Oscillating Positive Expiratory Pressure (OPEP) device (Aerobika) in patients with bronchiectasis. The goal is to determine whether the combination therapy reduces the frequency of acute exacerbations and improves patient symptoms compared to ACBT alone.
Primary Questions:
Does the use of ACBT plus Aerobika reduce the number of acute exacerbations in patients with bronchiectasis who experience ≥3 exacerbations per year?
What symptoms and adverse events are observed in participants using the Aerobika device?
Study Design:
This is a single-center, randomized, controlled clinical trial conducted at Chungbuk National University Hospital in Korea. 100 adult patients diagnosed with bronchiectasis and having ≥3 acute exacerbations within 1 year will be enrolled and randomized into two groups (1:1):
Active Cycle of Breathing Technique (ACBT) group
Active Cycle of Breathing Technique (ACBT) and Oscillatory Positive Expiratory Pressure (OPEP) group
The intervention period lasts 12 months, with clinic visits scheduled at 0, 1, 3, 6, 9, and 12 months.
Participation Involves:
Use of ACBT with or without Aerobika daily for 12 months
In-person clinic visits every 1 to 3 months
Monthly phone follow-ups to assess symptoms and adverse events
Completion of questionnaires (mMRC, BHQ, CAT) and clinical tests including PFT and laboratory tests
Tracking of exacerbation frequency, sputum volume, and quality
The 2 groups in the trial
- Active Cycle of Breathing Technique (ACBT) groupExisting treatment, for comparison
patients with bronchiectasis using ACBT
- Active Cycle of Breathing Technique (ACBT) and Oscillatory Positive Expiratory Pressure (OPEP) groupTreatment being tested
Patients with bronchiectasis using ACBT and OPEP simultaneously
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparison of Effectiveness Between Active Cycle of Breathing Techniques (ACBT) and Oscillating Positive Expiratory Pressure (OPEP, Aerobika) Device Assisted Treatment in Patients With Bronchiectasis in Korea : Randomized Controlled Trials
- Plain-language title
- Breathing exercises with or without the Aerobika device for bronchiectasisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 25 June 2025